Pharmaceutical Care for Severe Drug-Induced Thrombocytopenia Induced by Levofloxacin

ZOU Fengdan; CHANG Xinyu; LI Luyang; GUO Qi; GUO Guiming

doi:10.14009/j.issn.1672-2124.2021.05.028

您当前的位置：

首页 >

文章列表页 >

Pharmaceutical Care for Severe Drug-Induced Thrombocytopenia Induced by Levofloxacin

更新时间：2022-10-08

- Pharmaceutical Care for Severe Drug-Induced Thrombocytopenia Induced by Levofloxacin
- Vol. 21, Issue 5, Pages: 632-634(2021)
- 作者机构：
  
  1. 北京小汤山医院药学部
  2. 首都医科大学附属北京中医医院临床药学科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2021.05.028
  CLC： R969.3
- Published：2021，
扫描看全文
[1]邹凤丹,常馨予,李璐暘,国琦,郭桂明.左氧氟沙星致重度药源性血小板减少症的药学监护[J].中国医院用药评价与分析,2021,21(05):632-634.

ZOU Fengdan, CHANG Xinyu, LI Luyang, et al. Pharmaceutical Care for Severe Drug-Induced Thrombocytopenia Induced by Levofloxacin. [J]. 21(5):632-634(2021)
[1]邹凤丹,常馨予,李璐暘,国琦,郭桂明.左氧氟沙星致重度药源性血小板减少症的药学监护[J].中国医院用药评价与分析,2021,21(05):632-634. DOI： 10.14009/j.issn.1672-2124.2021.05.028.

ZOU Fengdan, CHANG Xinyu, LI Luyang, et al. Pharmaceutical Care for Severe Drug-Induced Thrombocytopenia Induced by Levofloxacin. [J]. 21(5):632-634(2021) DOI： 10.14009/j.issn.1672-2124.2021.05.028.

摘要

目的:探索左氧氟沙星致重度药源性血小板减少症的药学监护要点。方法:临床药师对发生重度药源性血小板减少症的患者进行用药分析及监护

认为血小板减少症最有可能由左氧氟沙星氯化钠注射液引起

建议医师立即停止使用该药

医师采纳建议并停用左氧氟沙星氯化钠注射液。结果:通过停止使用左氧氟沙星

同时进行升血小板、补充凝血因子的治疗

最终患者病情好转。结论:临床药师通过对患者进行药学监护

可以提高临床用药安全性。

Abstract

OBJECTIVE: To probe into the key points of pharmaceutical care for severe drug-induced thrombocytopenia induced by levofloxacin. METHODS: Clinical pharmacists performed medication analysis and monitoring on patients with severe drug-induced thrombocytopenia

and concluded that thrombocytopenia was most likely induced by levofloxacin sodium chloride injection

the clinicians were advised to stop using the drugs. The clinicians adopted the recommendation and discontinued levofloxacin sodium chloride injection. RESULTS: By discontinuing levofloxacin

along with platelet enhancement and coagulation factor supplement

the condition of the patient eventually improved. CONCLUSIONS: Clinical pharmacists can improve the safety of clinical medication by providing pharmaceutical care for patients.

关键词

左氧氟沙星药源性血小板减少症临床药师药学监护

Keywords

LevofloxacinDrug-induced thrombocytopeniaClinical pharmacistsPharmaceutical care

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Consultation Analysis on 174 Cases of Intra-Abdominal Infection by Clinical Pharmacists

Effectiveness of Participation of Pharmacists in Pain Management of Knee Replacement Under Accelerated Rehabilitation

Effect Evaluation of Intervention on Potentially Inappropriate Medication in Elderly Inpatients by Clinical Pharmacists

Analysis and Pharmaceutical Care of Hypertension Complicated with Proteinuria Induced by Anlotinib

Drug Use in 2 392 Oncology Medical Records Based on PCNE Classification

Related Author

CHENG Sheng

LUO Xiao

WEN Aiping

LIAO Yin

GUO Heng

ZHANG Chao

LI Dandan

ZHANG Yang

Related Institution

Dept. of Pharmacy, Beijing Friendship Hospital, Capital Medical University

Dept. of Orthopedics, Baoding No.1 Central Hospital

Dept. of Pharmacy, Baoding No.1 Central Hospital

Institute of Clinical Pharmacology, Peking University First Hospital

Dept.of Pharmacy, Peking University First Hospital

⁰